Axogen, Inc. Appoints Marc Began as Executive Vice President and General Counsel
Additionally, effective March 20, 2023, Mr. Began will be Axogen’s General Counsel, replacing Brad Ottinger, General Counsel and Chief Compliance Officer.
- Additionally, effective March 20, 2023, Mr. Began will be Axogen’s General Counsel, replacing Brad Ottinger, General Counsel and Chief Compliance Officer.
- “I want to thank Brad for his important contributions to Axogen, and welcome Marc to our team,” commented Ms. Zaderej.
- Mr. Began was most recently Executive Vice President, General Counsel, and Secretary of Abiomed until the completion of its acquisition by Johnson & Johnson late last year.
- Prior to Abiomed, he was Vice President of Intellectual Property with Boehringer Ingelheim, responsible for all medical device, pharmaceutical, and biologic intellectual property issues.